The purpose of HSCI Seed Grants is to provide early funding for innovative projects in any field of stem cell research. The awards put particular emphasis on projects that might be difficult to fund from other sources, either because a project is considered to be "high risk/high reward" or because the research is ineligible for federal funding under the current federal restrictions on human embryonic stem cell research. Seed grants are open to any investigator with a Harvard affiliation.

For the fifth consecutive year, HSCI awarded seed grants to scientists throughout the Harvard community to provide critical early funding for stem cell research. In May, eight seed grants totaling nearly $1.5 million were awarded to investigators selected from a large pool of applicants across the HSCI-affiliated institutions.

This year's grants will support stem cell research in a variety of targeted disease areas such as cancer, liver disease, nervous system disorders, and obesity, as well as research in broadly applicable areas of stem cell biology such as DNA repair, embryonic stem cell differentiation, and bone formation. As HSCI continues its work to support and grow the clinician scientist community in stem cell research, we are pleased to announce that three of this year’s recipients are MD/PhD scientists.

Click to view seed grant recipients from previous years: 2008 | 2007 | 2006 | 2005

2009 Seed Grant Recipients